PRA finalized the policy statement PS10/20 on the approach to determination of the availability of subordinated liabilities and preference shares in group own funds under Solvency II. PS10/20 contains the final policy in an updated version of the supervisory statement SS9/15 on group supervision as well as the feedback to responses received to the consultation paper CP16/19. PS10/20 is relevant to all insurance firms within the scope of group supervision under the Solvency II Directive and to the Society of Lloyd’s. The final policy took effect on April 30, 2020, which is the publication date of PS10/20.
SS9/15 sets out the expectations in respect of the Solvency II groups provisions. SS9/15 should be read in conjunction with the relevant European legislation, the Group Supervision Part of PRA Rulebook, the Solvency II Regulations 2015, and the PRA insurance approach document. The key changes in SS9/15 relate to Chapters 5A and 5B, which address availability of group own funds and regulatory determination on the availability of group own funds. Overall, the SS9/15 explains requirements regarding the following topics:
- Entities excluded from the scope of group supervision
- Choice of calculation method
- Group capital add-on
- Availability of group own funds and regulatory determination on the availability of group own funds
- Single own risk and solvency assessment report
- Single solvency and financial condition report
- Responsibilities of the relevant insurance group undertaking
- Supervision in the absence of third-country equivalence
The policy set out in PS10/20 has been designed in the context of the UK’s withdrawal from the European Union and entry into the transition period, during which time the UK remains subject to European law. PRA will keep the policy under review to assess whether any changes would be required due to changes in the UK regulatory framework at the end of the transition period, including those arising once any new arrangements with the European Union take effect.
Effective Date: April 30, 2020
Keywords: Europe, UK, Insurance, SS9/15, PS10/20, CP16/19, Solvency II, Group Supervision, PRA Rulebook, SFCR, SCR, Own Funds, PRA
Previous ArticleRBI Extends Reporting Timelines for Banks Amid Pandemic
EU published Directive 2021/338, which amends the Markets in Financial Instruments Directive (MiFID) II and the Capital Requirements Directives (CRD 4 and 5) to facilitate recovery from the COVID-19 crisis.
The Standing Committee of the European Free Trade Association (EFTA) recommended that a systemic risk buffer level of 4.5% for domestic exposures can be considered appropriate for addressing the identified systemic risks to the stability of the financial system in Norway.
In a recent statement, PRA clarified its approach to the application of certain EU regulatory technical standards and EBA guidelines on standardized and internal ratings-based approaches to credit risk, following the end of the Brexit transition.
In a recently published letter addressed to the G20 finance ministers and central bank governors, the FSB Chair Randal K. Quarles has set out the key FSB priorities for 2021.
EU published, in the Official Journal of the European Union, a corrigendum to the revised Capital Requirements Regulation (CRR2 or Regulation 2019/876).
ESAs published a joint supervisory statement on the effective and consistent application and on national supervision of the regulation on sustainability-related disclosures in the financial services sector (SFDR).
EC published a public consultation on the review of crisis management and deposit insurance frameworks in EU.
HKMA announced that enhancements will be made to the Special 100% Loan Guarantee of the SME Financing Guarantee Scheme (SFGS) and the application period will be extended to December 31, 2021.
EBA launched consultations on the regulatory and implementing technical standards on cooperation and information exchange between competent authorities involved in prudential supervision of investment firms.
BoE issued a letter to the CEOs of eight major UK banks that are in scope of the first Resolvability Assessment Framework (RAF) reporting and disclosure cycle.